Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report

Inv(16)(p13.1q22) in acute myeloid leukemia (AML) is a common chromosomal abnormality. It leads to the core-binding factor ß-subunit (CBFβ)/smooth muscle myosin heavy chain 11 (MYH11) fusion gene. Different breakpoints were observed in the CBFβ gene at 16q22 and the MYH11 gene at 16p13.1. For this r...

Full description

Bibliographic Details
Main Authors: Wenyi Zhang, Hainan Wang, Peilei Zhang, Hongliang Li, Xiaoli Ma, Hongxing Liu
Format: Article
Language:English
Published: Associação Brasileira de Divulgação Científica 2021-10-01
Series:Brazilian Journal of Medical and Biological Research
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200501&tlng=en
_version_ 1798021955386867712
author Wenyi Zhang
Hainan Wang
Peilei Zhang
Hongliang Li
Xiaoli Ma
Hongxing Liu
author_facet Wenyi Zhang
Hainan Wang
Peilei Zhang
Hongliang Li
Xiaoli Ma
Hongxing Liu
author_sort Wenyi Zhang
collection DOAJ
description Inv(16)(p13.1q22) in acute myeloid leukemia (AML) is a common chromosomal abnormality. It leads to the core-binding factor ß-subunit (CBFβ)/smooth muscle myosin heavy chain 11 (MYH11) fusion gene. Different breakpoints were observed in the CBFβ gene at 16q22 and the MYH11 gene at 16p13.1. For this reason, different CBFβ/MYH11 fusion genes are generated, with more than 13 types having been reported to date. Type I CBFβ/MYH11 fusion transcripts are very rare, with only 10 cases being reported to date. This case report describes a primary AML patient with inv(16)(p13.1q22) and a rare type I CBFβ/MYH11 fusion gene. The morphological analysis did not conform to the typical M4eo. Abnormal eosinophils were less than 5%, and there was obvious dysgranulopoiesis. The patient was in hematological and genetic remission for 487 days after the initial chemotherapy cycles. However, the CBFβ/MYH11 fusion had been constantly positive. Moreover, the presence of non-type A fusions may affect its biology and clinical prognosis. Therefore, further studies on understanding its biological and prognostic significance are essential.
first_indexed 2024-04-11T17:21:55Z
format Article
id doaj.art-ff231c5481eb47c1a36224f5096e3ca2
institution Directory Open Access Journal
issn 1414-431X
language English
last_indexed 2024-04-11T17:21:55Z
publishDate 2021-10-01
publisher Associação Brasileira de Divulgação Científica
record_format Article
series Brazilian Journal of Medical and Biological Research
spelling doaj.art-ff231c5481eb47c1a36224f5096e3ca22022-12-22T04:12:28ZengAssociação Brasileira de Divulgação CientíficaBrazilian Journal of Medical and Biological Research1414-431X2021-10-01541210.1590/1414-431x2021e11605Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case reportWenyi Zhanghttps://orcid.org/0000-0001-8471-6396Hainan Wanghttps://orcid.org/0000-0003-0471-4361Peilei Zhanghttps://orcid.org/0000-0001-7667-2127Hongliang Lihttps://orcid.org/0000-0002-1084-5651Xiaoli Mahttps://orcid.org/0000-0003-3465-3424Hongxing Liuhttps://orcid.org/0000-0002-0547-5721Inv(16)(p13.1q22) in acute myeloid leukemia (AML) is a common chromosomal abnormality. It leads to the core-binding factor ß-subunit (CBFβ)/smooth muscle myosin heavy chain 11 (MYH11) fusion gene. Different breakpoints were observed in the CBFβ gene at 16q22 and the MYH11 gene at 16p13.1. For this reason, different CBFβ/MYH11 fusion genes are generated, with more than 13 types having been reported to date. Type I CBFβ/MYH11 fusion transcripts are very rare, with only 10 cases being reported to date. This case report describes a primary AML patient with inv(16)(p13.1q22) and a rare type I CBFβ/MYH11 fusion gene. The morphological analysis did not conform to the typical M4eo. Abnormal eosinophils were less than 5%, and there was obvious dysgranulopoiesis. The patient was in hematological and genetic remission for 487 days after the initial chemotherapy cycles. However, the CBFβ/MYH11 fusion had been constantly positive. Moreover, the presence of non-type A fusions may affect its biology and clinical prognosis. Therefore, further studies on understanding its biological and prognostic significance are essential.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200501&tlng=enAcute myeloid leukemiaType I CBFβ/MYH11Inv(16)(p13.1q22)Case report
spellingShingle Wenyi Zhang
Hainan Wang
Peilei Zhang
Hongliang Li
Xiaoli Ma
Hongxing Liu
Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
Brazilian Journal of Medical and Biological Research
Acute myeloid leukemia
Type I CBFβ/MYH11
Inv(16)(p13.1q22)
Case report
title Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
title_full Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
title_fullStr Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
title_full_unstemmed Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
title_short Rare type I CBFβ/MYH11 fusion transcript in primary acute myeloid leukemia with inv(16)(p13.1q22): a case report
title_sort rare type i cbfβ myh11 fusion transcript in primary acute myeloid leukemia with inv 16 p13 1q22 a case report
topic Acute myeloid leukemia
Type I CBFβ/MYH11
Inv(16)(p13.1q22)
Case report
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S0100-879X2021001200501&tlng=en
work_keys_str_mv AT wenyizhang raretypeicbfbmyh11fusiontranscriptinprimaryacutemyeloidleukemiawithinv16p131q22acasereport
AT hainanwang raretypeicbfbmyh11fusiontranscriptinprimaryacutemyeloidleukemiawithinv16p131q22acasereport
AT peileizhang raretypeicbfbmyh11fusiontranscriptinprimaryacutemyeloidleukemiawithinv16p131q22acasereport
AT hongliangli raretypeicbfbmyh11fusiontranscriptinprimaryacutemyeloidleukemiawithinv16p131q22acasereport
AT xiaolima raretypeicbfbmyh11fusiontranscriptinprimaryacutemyeloidleukemiawithinv16p131q22acasereport
AT hongxingliu raretypeicbfbmyh11fusiontranscriptinprimaryacutemyeloidleukemiawithinv16p131q22acasereport